TEVA PHARMACEUTICAL INDUSTRIES LTD financial data

Symbol
TEVA on NYSE, TEVJF on OTC
Location
Tel Aviv
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 03 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 106% % 16%
Quick Ratio 28% % -0.6%
Debt-to-equity 463% % -16%
Return On Equity 20% %
Return On Assets 3.5% %
Operating Margin 12% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,149,812,898 shares 1.4%
Entity Public Float $18,160,000,000 USD -0.87%
Common Stock, Value, Issued $58,000,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 1,145,000,000 shares 1.2%
Weighted Average Number of Shares Outstanding, Diluted 1,163,000,000 shares 2.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $1,500,000,000 USD
Revenue from Contract with Customer, Excluding Assessed Tax $17,258,000,000 USD 4.3%
Selling and Marketing Expense $2,686,000,000 USD 5.7%
General and Administrative Expense $1,287,000,000 USD 11%
Operating Income (Loss) $2,157,000,000 USD
Nonoperating Income (Expense) $934,000,000 USD 4.8%
Income Tax Expense (Benefit) $180,000,000 USD -127%
Net Income (Loss) Attributable to Parent $1,410,000,000 USD
Earnings Per Share, Basic 1.23 USD/shares
Earnings Per Share, Diluted 1.21 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $3,556,000,000 USD 7.8%
Accounts Receivable, after Allowance for Credit Loss, Current $3,709,000,000 USD 21%
Inventory, Net $3,179,000,000 USD 5.7%
Other Assets, Current $539,000,000 USD 32%
Assets, Current $13,946,000,000 USD 11%
Deferred Income Tax Assets, Net $2,191,000,000 USD 22%
Property, Plant and Equipment, Net $4,080,000,000 USD -11%
Operating Lease, Right-of-Use Asset $345,000,000 USD -6%
Goodwill $16,000,000,000 USD 5.6%
Other Assets, Noncurrent $405,000,000 USD -12%
Assets $40,748,000,000 USD 3.6%
Accounts Payable, Current $225,000,000 USD 42%
Employee-related Liabilities, Current $739,000,000 USD 18%
Liabilities, Current $13,456,000,000 USD 5.2%
Operating Lease, Liability, Noncurrent $288,000,000 USD -2.7%
Other Liabilities, Noncurrent $3,808,000,000 USD -5.5%
Liabilities $32,834,000,000 USD -2.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,391,000,000 USD 24%
Retained Earnings (Accumulated Deficit) $13,762,000,000 USD 9.3%
Stockholders' Equity Attributable to Parent $7,910,000,000 USD 47%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $7,914,000,000 USD 47%
Liabilities and Equity $40,748,000,000 USD 3.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,649,000,000 USD 32%
Net Cash Provided by (Used in) Financing Activities $2,151,000,000 USD -20%
Net Cash Provided by (Used in) Investing Activities $737,000,000 USD -6.9%
Common Stock, Shares Authorized 2,495,000,000 shares 0%
Common Stock, Shares, Issued 1,257,000,000 shares 1.4%
Common Stock, Par or Stated Value Per Share 0.1 ILS/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $256,000,000 USD 246%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3,556,000,000 USD 7.8%
Deferred Tax Assets, Valuation Allowance $2,342,000,000 USD 16%
Deferred Tax Assets, Gross $2,191,000,000 USD 22%
Operating Lease, Liability $382,000,000 USD -0.26%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $2,168,000,000 USD
Lessee, Operating Lease, Liability, to be Paid $439,000,000 USD -11%
Property, Plant and Equipment, Gross $8,807,000,000 USD -2%
Operating Lease, Liability, Current $288,000,000 USD -2.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two $97,000,000 USD -4.9%
Lessee, Operating Lease, Liability, to be Paid, Year One $116,000,000 USD -3.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.069 pure 6.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three $71,000,000 USD -12%
Unrecognized Tax Benefits $596,000,000 USD 33%
Lessee, Operating Lease, Liability, to be Paid, Year Four $50,000,000 USD -12%
Additional Paid in Capital $28,133,000,000 USD 1.3%
Amortization of Intangible Assets $581,000,000 USD -1.2%